Replies to post #83376 on Biotech Values

[mouton29]

<<MNTA- anything noteworthy said at the Rodman and Renshaw conference?>>

I listened to the 21 minute presentation. Slides and audio are available via link on the momentapharma.com website.

I did not hear anything new.

Of possible interest to mac users, the slides worked on my mac but not the audio. Listening using internet explorer on my mac via crossover, the audio worked but not the slides, but between the mac side and crossover, I heard and saw the whole thing.

[DewDiligence]

MNTA – anything noteworthy said at the Rodman and Renshaw conference?

This was the most consequential excerpt:

“Because there was [bulk heparin] contamination in China, that has been another approval hurdle for us… We’ve had to go through a full set of inspections on our supply chain and I am pleased to say it is now complete and we have no areas of concern on our supply chain, so we really feel at this point in time that the FDA has what they need in hand to approve this product.”

This is the most confidant Wheeler has ever sounded on the outcome of the FDA’s review.